The studyfound that diabetics taking the semaglutide-containing drugs were over four times more likely to get a NAION diagnosis.
Representational image (iStock)
Popular weight loss drugs have been linked to an uncommon eye-blinding condition. A team of researchers led by Massachusetts Eye and Ear Hospital in the US found that patients with obesity who were prescribed weight loss drugs were over seven times more likely to be diagnosed with ‘Non-Arteritic Anterior Ischemic Optic Neuropathy’, causing sudden vision loss in one eye.